Rare Multi-Provider Endocrinology Practice — $883K Revenue & Growing | Phoenix, AZ!
Sale Includes 10,000+ Patient Charts, 3-Physician Platform & Proven Scalability to $250K–$400K+ EBITDA
Step into ownership of a high-demand, multi-provider endocrinology and diabetes specialty practice operating in one of Phoenix's most desirable medical corridors. Founded in 2019, this practice reached full clinical capacity within just 24 months — not through marketing, but through physician reputation and an organically built referral network that continues to drive demand today. Quite simply, this practice is bursting at the seams. Patient demand has outpaced the space available, the panel has closed, and the founding physicians are actively seeking a strategic partner or acquirer with the resources and vision to take this platform to the next level.
With 10,000+ active patient charts and a recurring chronic care model, this is a cash-flow-positive platform with a clear, documented path to significantly higher earnings under expanded operations.
With 6 years of successful operation, this practice boasts:

2025 revenue of $883,000 — representing 15% growth from 2023 and an accelerating trajectory
Net income of $96,000 in 2025 with pro forma EBITDA of $250,000–$400,000+ upon facility expansion and provider additions.
3-provider physician platform with all providers committed through transition and open to long-term continuation (8–12 years).
10,000+ patient charts generating predictable, recurring insurance-based revenue.
Panel closure due to demand — growth is constrained by space, not patient volume.
Prime Phoenix location serving a 3-mile population of 155,000+ with average household income of ~$93,000.
Outpatient, insurance-based model with strong payer mix and chronic care retention.
Lease flexibility — current lease expires October 2026 with flexibility to renegotiate or expand.

This practice operates in one of the most structurally sound segments of healthcare M&A. Endocrinology demand is driven by the diabetes and obesity epidemic, an aging population, and a chronic national shortage of endocrinology specialists — creating a durable, defensible patient base with minimal competitive risk. Maricopa County's position as one of the fastest-growing counties in the U.S. adds a powerful long-term demographic tailwind. The current facility constraint is not a liability — it is the clearest possible signal that demand is real, proven, and ready to be unlocked.

Bonus Opportunity:
Adding NP/PA providers (~$40,000 revenue each), expanding into GLP-1 weight management, infusion therapy, and chronic care management (CCM) services, and renegotiating payer contracts represent near-term, low-capital levers to drive EBITDA to $250,000–$400,000+ — making this an exceptional platform for a DSO-style rollup, private equity, or strategic hospital acquirer.
This is a turnkey opportunity ideal for:

Hospital systems, health networks, or physician groups seeking to add a high-demand endocrinology platform with an established referral base and patient panel.
Private equity or DSO-style investors building a multi-site specialty care platform in the Phoenix metro.
Established physicians or practice management groups looking to acquire a proven, capacity-constrained practice with clear upside.

Ideal Buyers:
This practice is not being sold because business is slow — it's being sold because business is too good to handle alone. The physicians have built something exceptional and are bursting at the seams, ready to hand the reins to a strategic partner or acquirer who can invest in the space, add the providers, and unlock the demand that is already there and waiting. Specialty practices of this caliber — with a multi-physician platform, 10,000+ recurring patient charts, and documented demand exceeding current capacity — are exceptionally rare acquisition opportunities. Qualified buyers are encouraged to act promptly.